“Absence of Specified Microorganisms” versus “Absence of Objectionable Microorganisms” of the Microbial Limits Tests for Non-Sterile Pharmaceuticals

Research output: Journal Publications and ReviewsRGC 22 - Publication in policy or professional journal

View graph of relations

Author(s)

  • Desmond Keith O'TOOLE
  • Hon-yeung CHEUNG

Related Research Unit(s)

Detail(s)

Original languageEnglish
Pages (from-to)64 - 65
Journal / PublicationHong Kong Pharmaceutical Journal
Volume16
Issue number2
Publication statusPublished - 30 Jun 2009

Abstract

Different types of Microbial Limits Tests have been introduced and implemented since the outbreaks of microbial diseases in the 70’s due to the uses of medications contaminated with unexpected pathogenic organisms. The tests were designed to ensure a product is safe for use. The monographs described in the official compendia, however, are merely the minimal requirements and should not be taken as proof that the product is suitable for sale from a microbiological perspective. In this article, the differences between “Absence of Specific Microorganisms” and “Absence of Objectionable Microorganisms” are highlighted and discussed.

Research Area(s)

  • Microbial limits tests, non-sterile products, USP, FDA, CFR, Microbiological contamination